Adapting the Penny Chatbot for Perinatal OUD Patients: COPILOT
Key facts
- Who runs it
- University of Pennsylvania
- Where
- Philadelphia, United StatesSee the 2 sites
- Trial code
- Status
- Recruiting
- People taking part
- 20 people, planned
- Started
- 1 Jan 2026
- Expected to end
- 31 May 2027
- Type of study
- Interventional
- Treatments tested
- Penny COPILOT
- Record updated
- 28 July 2026
Who can take part
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Biological females who are currently pregnant or within 6 weeks postpartum
- Able to read, write, and speak English at a 6th grade level
- Diagnosed and receiving treatment for, or willing to receive treatment for opioid use disorder
- Receiving prenatal care and OUD care at a Penn affiliated hospital
Who cannot take part
- -Current untreated psychosis, mania, or active suicidality as assessed by the Mini International Neuropsychiatric Interview (MINI)
This trial is currently available in United States.
- Hospital of the University of Pennsylvania (HUP)Philadelphia, United StatesContact: Emma Farber, BATaking people
- University of PennsylvaniaPhiladelphia, United StatesContact: Sara L Kornfield, PhDNot yet recruiting
About the trial
What the trial wants to find out
To address both loneliness and engagement in perinatal and OUD care among perinatal women, the investigators plan to adapt an existing texting support chatbot, Penny, to make it appropriate for use by women who are pregnant and postpartum and dealing with OUD. The newly adapted chatbot, Penny COPILOT, will allow for two way short message service (SMS) messaging to respond appropriately and accurately to user generated input. The investigative team, in collaboration with the Penn Mixed Methods Research Lab (MMRL) and Penn's Way 2 Health Team, will use intervention mapping guided by the Consolidated Framework for Implementation Science. The investigators will conduct a needs assessment, assemble an advisory board, engage in pretesting to ensure safety and refine content, and pilot test the resultant adapted Penny COPILOT in a sample of 20 perinatal women with OUD to evaluate acceptability, feasibility, and patient satisfaction. The goal is to develop and refine an acceptable, feasible, and satisfactory supportive texting chatbot to promote patient engagement in perinatal and OUD care and decrease perceived loneliness.
The group in the trial
- Chatbot InterventionTreatment being tested
This is a single arm study designed to assess the acceptability and feasibility of the chatbot.
Treatment: Penny COPILOT
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 28 July 2026